A chemist from RUDN University has proposed a new method for the synthesis of secondary propargylamine used to create antidepressants, drugs for Parkinson's disease and other neurodegenerative diseases, as well as malaria. It differs from the known methods in its simplicity and stability of the resulting substance. The paper was published in the Journal of Organic Chemistry.